Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes.

del Rey M, O'Hagan K, Dellett M, Aibar S, Colyer HA, Alonso ME, Díez-Campelo M, Armstrong RN, Sharpe DJ, Gutiérrez NC, García JL, De Las Rivas J, Mills KI, Hernández-Rivas JM.

Leukemia. 2013 Mar;27(3):610-8. doi: 10.1038/leu.2012.253. Epub 2012 Aug 31.

PMID:
22936014
2.

CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.

Zhao X, Yang F, Li S, Liu M, Ying S, Jia X, Wang X.

Br J Haematol. 2014 Jun;165(5):649-58. doi: 10.1111/bjh.12811. Epub 2014 Mar 6.

PMID:
24601943
3.

Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.

Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M.

Cancer Res. 2006 Jun 15;66(12):6118-28.

4.

Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.

Shi H, Guo J, Duff DJ, Rahmatpanah F, Chitima-Matsiga R, Al-Kuhlani M, Taylor KH, Sjahputera O, Andreski M, Wooldridge JE, Caldwell CW.

Carcinogenesis. 2007 Jan;28(1):60-70. Epub 2006 Jun 14.

PMID:
16774933
5.

Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.

Qian J, Chen Z, Wang W, Cen J, Xue Y.

Oncol Rep. 2005 Nov;14(5):1189-97.

PMID:
16211284
6.

Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.

Hopfer O, Nolte F, Mossner M, Komor M, Kmetsch A, Benslasfer O, Reissmann M, Nowak D, Hoelzer D, Thiel E, Hofmann WK.

Eur J Haematol. 2012 Feb;88(2):144-53. doi: 10.1111/j.1600-0609.2011.01715.x. Epub 2011 Nov 22.

PMID:
21967505
7.

The lower risk MDS patient at risk of rapid progression.

Mittelman M, Oster HS, Hoffman M, Neumann D.

Leuk Res. 2010 Dec;34(12):1551-5. doi: 10.1016/j.leukres.2010.05.023. Epub 2010 Jun 22. Review.

PMID:
20573398
8.

Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.

Lin J, Wang YL, Qian J, Yao DM, Zhu ZH, Qian Z, Xu WR.

Leuk Res. 2010 Aug;34(8):991-4. doi: 10.1016/j.leukres.2010.01.003. Epub 2010 Jan 29.

PMID:
20116099
9.

Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.

Hofmann WK, Takeuchi S, Takeuchi N, Thiel E, Hoelzer D, Koeffler HP.

Leuk Res. 2006 Nov;30(11):1347-53. Epub 2006 May 8.

PMID:
16682076
10.

450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.

Cahill N, Bergh AC, Kanduri M, Göransson-Kultima H, Mansouri L, Isaksson A, Ryan F, Smedby KE, Juliusson G, Sundström C, Rosén A, Rosenquist R.

Leukemia. 2013 Jan;27(1):150-8. doi: 10.1038/leu.2012.245. Epub 2012 Aug 27.

PMID:
22922567
11.

Differentially expressed genes in adult familial myelodysplastic syndromes.

Pradhan A, Mijovic A, Mills K, Cumber P, Westwood N, Mufti GJ, Rassool FV.

Leukemia. 2004 Mar;18(3):449-59.

PMID:
14737073
12.

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.

Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, Jädersten M, Killick S, Verma A, Norbury CJ, Hellström-Lindberg E, Wainscoat JS, Boultwood J.

Leukemia. 2010 Apr;24(4):756-64. doi: 10.1038/leu.2010.31. Epub 2010 Mar 11.

PMID:
20220779
13.

Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.

Cechova H, Lassuthova P, Novakova L, Belickova M, Stemberkova R, Jencik J, Stankova M, Hrabakova P, Pegova K, Zizkova H, Cermak J.

Neoplasma. 2012;59(2):168-74.

PMID:
22248274
14.
15.

Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.

Fabiani E, Leone G, Giachelia M, D'alo' F, Greco M, Criscuolo M, Guidi F, Rutella S, Hohaus S, Voso MT.

Leuk Lymphoma. 2010 Dec;51(12):2275-84. doi: 10.3109/10428194.2010.528093. Epub 2010 Nov 15.

PMID:
21077739
16.

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.

Santamaría C, Muntión S, Rosón B, Blanco B, López-Villar O, Carrancio S, Sánchez-Guijo FM, Díez-Campelo M, Alvarez-Fernández S, Sarasquete ME, de las Rivas J, González M, San Miguel JF, Del Cañizo MC.

Haematologica. 2012 Aug;97(8):1218-24. doi: 10.3324/haematol.2011.054437. Epub 2012 Feb 27.

17.

High-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B gene.

Uchida T, Kinoshita T, Hotta T, Murate T.

Leuk Lymphoma. 1998 Dec;32(1-2):9-18. Review.

PMID:
10036997
18.

Genome-wide screen of promoter methylation identifies novel markers in melanoma.

Koga Y, Pelizzola M, Cheng E, Krauthammer M, Sznol M, Ariyan S, Narayan D, Molinaro AM, Halaban R, Weissman SM.

Genome Res. 2009 Aug;19(8):1462-70. doi: 10.1101/gr.091447.109. Epub 2009 Jun 2.

19.

Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.

Hopfer O, Komor M, Koehler IS, Freitag C, Schulze M, Hoelzer D, Thiel E, Hofmann WK.

Leuk Res. 2009 Mar;33(3):434-42. doi: 10.1016/j.leukres.2008.08.014. Epub 2008 Sep 30.

PMID:
18829110
20.

Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.

Yang Y, Zhang Q, Xu F, Wu L, He Q, Li X.

J Cancer Res Clin Oncol. 2012 May;138(5):729-37. doi: 10.1007/s00432-012-1151-0. Epub 2012 Jan 15.

PMID:
22246278

Supplemental Content

Support Center